These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24451633)

  • 21. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD; Patel Y; Kell DB
    Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods.
    Houghten RA; Pinilla C; Giulianotti MA; Appel JR; Dooley CT; Nefzi A; Ostresh JM; Yu Y; Maggiora GM; Medina-Franco JL; Brunner D; Schneider J
    J Comb Chem; 2008; 10(1):3-19. PubMed ID: 18067268
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular Scaffold Hopping via Holistic Molecular Representation.
    Grisoni F; Schneider G
    Methods Mol Biol; 2021; 2266():11-35. PubMed ID: 33759119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Privileged scaffolds for library design and drug discovery.
    Welsch ME; Snyder SA; Stockwell BR
    Curr Opin Chem Biol; 2010 Jun; 14(3):347-61. PubMed ID: 20303320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinatorial library design from reagent pharmacophore fingerprints.
    Chen H; Engkvist O; Blomberg N
    Methods Mol Biol; 2011; 685():135-52. PubMed ID: 20981522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical structure montages as catalysts for design and discovery.
    Njarðarson JT
    Future Med Chem; 2012 May; 4(8):951-4. PubMed ID: 22650237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conserved core substructures in the overlay of protein-ligand complexes.
    Finzel BC; Akavaram R; Ragipindi A; Van Voorst JR; Cahn M; Davis ME; Pokross ME; Sheriff S; Baldwin ET
    J Chem Inf Model; 2011 Aug; 51(8):1931-41. PubMed ID: 21736376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is next for small-molecule drug discovery?
    Doweyko AM; Doweyko LM
    Future Med Chem; 2009 Sep; 1(6):1029-36. PubMed ID: 21425992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Network measures for chemical library design.
    Sukumar N; Krein MP; Prabhu G; Bhattacharya S; Sen S
    Drug Dev Res; 2014 Sep; 75(6):402-11. PubMed ID: 25195584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods for combinatorial and parallel library design.
    Schnur DM; Beno BR; Tebben AJ; Cavallaro C
    Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists.
    Raveglia LF; Giardina GA
    Future Med Chem; 2009 Sep; 1(6):1019-23. PubMed ID: 21425990
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of 2D fingerprints for scaffold hopping.
    Gardiner EJ; Holliday JD; O'Dowd C; Willett P
    Future Med Chem; 2011 Mar; 3(4):405-14. PubMed ID: 21452977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The many roles of molecular complexity in drug discovery.
    Méndez-Lucio O; Medina-Franco JL
    Drug Discov Today; 2017 Jan; 22(1):120-126. PubMed ID: 27575998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-on drugs: how far should chemists look?
    Giordanetto F; Boström J; Tyrchan C
    Drug Discov Today; 2011 Aug; 16(15-16):722-32. PubMed ID: 21658467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.
    Dimova D; Hu Y; Bajorath J
    J Med Chem; 2012 Nov; 55(22):10220-8. PubMed ID: 23050678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diversity-oriented synthesis: producing chemical tools for dissecting biology.
    O' Connor CJ; Beckmann HS; Spring DR
    Chem Soc Rev; 2012 Jun; 41(12):4444-56. PubMed ID: 22491328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can we discover pharmacological promiscuity early in the drug discovery process?
    Peters JU; Hert J; Bissantz C; Hillebrecht A; Gerebtzoff G; Bendels S; Tillier F; Migeon J; Fischer H; Guba W; Kansy M
    Drug Discov Today; 2012 Apr; 17(7-8):325-35. PubMed ID: 22269136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting cancer using scaffold-hopping approaches: illuminating SAR to improve drug design.
    Shivani ; Abdul Rahaman TA; Chaudhary S
    Drug Discov Today; 2024 Sep; 29(9):104115. PubMed ID: 39067613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SAR Matrix Method for Large-Scale Analysis of Compound Structure-Activity Relationships and Exploration of Multitarget Activity Spaces.
    Hu Y; Bajorath J
    Methods Mol Biol; 2018; 1825():339-352. PubMed ID: 30334212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.